Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.

× No keyword cloud information.

20 in total

Review 1. Chemistry and biology of multicomponent reactions.

Authors: Alexander Dömling; Wei Wang; Kan Wang
Journal: Chem Rev Date: 2012-03-22 Impact factor: 60.622

2. 1,4-Diazaspiro[2.2]pentanes as a flexible platform for the synthesis of diamine-bearing stereotriads.

Authors: Jared W Rigoli; Luke A Boralsky; John C Hershberger; Dagmara Marston; Alan R Meis; Ilia A Guzei; Jennifer M Schomaker
Journal: J Org Chem Date: 2012-02-14 Impact factor: 4.354

Review 3. The economies of synthesis.

Authors: Timothy Newhouse; Phil S Baran; Reinhard W Hoffmann
Journal: Chem Soc Rev Date: 2009-08-21 Impact factor: 54.564

4. Development of a concise synthesis of (-)-oseltamivir (Tamiflu).

Authors: Barry M Trost; Ting Zhang
Journal: Chemistry Date: 2011-03-01 Impact factor: 5.236

5. Glycal Metallanitrenes for 2-Amino Sugar Synthesis: Amidoglycosylation of Gulal-, Allal-, Glucal-, and Galactal 3-Carbamates.

Authors: Simran Buttar; Julia Caine; Evelyne Goné; Reneé Harris; Jennifer Gillman; Roxanne Atienza; Ritu Gupta; Kimberly M Sogi; Lauren Jain; Nadia C Abascal; Yetta Levine; Lindsay M Repka; Christian M Rojas
Journal: J Org Chem Date: 2018-07-06 Impact factor: 4.354

Review 9. CuAAC click chemistry accelerates the discovery of novel chemical scaffolds as promising protein tyrosine phosphatases inhibitors.

Authors: X-P He; J Xie; Y Tang; J Li; G-R Chen
Journal: Curr Med Chem Date: 2012 Impact factor: 4.530

10. Influenza a virus entry: implications in virulence and future therapeutics.

Authors: Emily Rumschlag-Booms; Lijun Rong
Journal: Adv Virol Date: 2013-01-09

Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.